222 related articles for article (PubMed ID: 15162529)
101. Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected Cells.
Fergusson JR; Wallace Z; Connolly MM; Woon AP; Suckling RJ; Hine DW; Barber C; Bunjobpol W; Choi BS; Crespillo S; Dembek M; Dieckmann N; Donoso J; Godinho LF; Grant T; Howe D; McCully ML; Perot C; Sarkar A; Seifert FU; Singh PK; Stegmann KA; Turner B; Verma A; Walker A; Leonard S; Maini MK; Wiederhold K; Dorrell L; Simmons R; Knox A
Hepatology; 2020 Nov; 72(5):1528-1540. PubMed ID: 32770836
[TBL] [Abstract][Full Text] [Related]
102. Cholesterol accumulation on dendritic cells reverses chronic hepatitis B virus infection-induced dysfunction.
Zhao H; Yu Y; Wang Y; Zhao L; Yang A; Hu Y; Pan Z; Wang Z; Yang J; Han Q; Tian Z; Zhang J
Cell Mol Immunol; 2022 Dec; 19(12):1347-1360. PubMed ID: 36369367
[TBL] [Abstract][Full Text] [Related]
103. Modulation of the function of dendritic cells in adolescents with chronic HBV infection by IFN-λ1.
Sun H; Bi L; Zhou J; Zhou D; Liu Y; Jin G; Yan W
Int J Clin Exp Pathol; 2015; 8(2):1743-51. PubMed ID: 25973063
[TBL] [Abstract][Full Text] [Related]
104. MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance.
Yang S; Wang L; Pan W; Bayer W; Thoens C; Heim K; Dittmer U; Timm J; Wang Q; Yu Q; Luo J; Liu Y; Hofmann M; Thimme R; Zhang X; Chen H; Wang H; Feng X; Yang X; Lu Y; Lu M; Yang D; Liu J
J Hepatol; 2019 Oct; 71(4):685-698. PubMed ID: 31173811
[TBL] [Abstract][Full Text] [Related]
105. Prostaglandin E2 facilitates Hepatitis B virus replication by impairing CTL function.
Li X; Xie T; Gao L; Ma C; Yang X; Liang X
Mol Immunol; 2018 Nov; 103():243-250. PubMed ID: 30321734
[TBL] [Abstract][Full Text] [Related]
106. Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses.
Wang XH; Qin Y; Hu MH; Xie Y
World J Gastroenterol; 2005 Sep; 11(36):5614-20. PubMed ID: 16237753
[TBL] [Abstract][Full Text] [Related]
107. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.
Maini MK; Boni C; Ogg GS; King AS; Reignat S; Lee CK; Larrubia JR; Webster GJ; McMichael AJ; Ferrari C; Williams R; Vergani D; Bertoletti A
Gastroenterology; 1999 Dec; 117(6):1386-96. PubMed ID: 10579980
[TBL] [Abstract][Full Text] [Related]
108. Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study.
Chen M; Li YG; Zhang DZ; Wang ZY; Zeng WQ; Shi XF; Guo Y; Guo SH; Ren H
World J Gastroenterol; 2005 Mar; 11(12):1806-8. PubMed ID: 15793869
[TBL] [Abstract][Full Text] [Related]
109. The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and Function.
van der Aa E; Buschow SI; Biesta PJ; Janssen HL; Woltman AM
PLoS One; 2016; 11(8):e0161235. PubMed ID: 27529176
[TBL] [Abstract][Full Text] [Related]
110. Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro.
Rossi M; Vecchi A; Tiezzi C; Barili V; Fisicaro P; Penna A; Montali I; Daffis S; Fletcher SP; Gaggar A; Medley J; Graupe M; Lad L; Loglio A; Soffredini R; Borghi M; Pollicino T; Musolino C; Alfieri A; Brillo F; Laccabue D; Massari M; Boarini C; Abbati G; Pedrazzi G; Missale G; Lampertico P; Ferrari C; Boni C
Gut; 2023 Nov; 72(11):2123-2137. PubMed ID: 36717219
[TBL] [Abstract][Full Text] [Related]
111. The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells.
Jochems C; Fantini M; Fernando RI; Kwilas AR; Donahue RN; Lepone LM; Grenga I; Kim YS; Brechbiel MW; Gulley JL; Madan RA; Heery CR; Hodge JW; Newton R; Schlom J; Tsang KY
Oncotarget; 2016 Jun; 7(25):37762-37772. PubMed ID: 27192116
[TBL] [Abstract][Full Text] [Related]
112. Characteristics of Impaired Dendritic Cell Function in Patients With Hepatitis B Virus Infection.
Yonejima A; Mizukoshi E; Tamai T; Nakagawa H; Kitahara M; Yamashita T; Arai K; Terashima T; Iida N; Fushimi K; Okada H; Yamashita T; Sakai Y; Honda M; Kaneko S
Hepatology; 2019 Jul; 70(1):25-39. PubMed ID: 30938456
[TBL] [Abstract][Full Text] [Related]
113. HBV-Specific CD8+ T-Cell Tolerance in the Liver.
Baudi I; Kawashima K; Isogawa M
Front Immunol; 2021; 12():721975. PubMed ID: 34421926
[TBL] [Abstract][Full Text] [Related]
114. The L60V variation in hepatitis B virus core protein elicits new epitope-specific cytotoxic T lymphocytes and enhances viral replication.
Zhang Y; Ren Y; Wu Y; Zhao B; Qiu L; Li X; Xu D; Liu J; Gao GF; Meng S
J Virol; 2013 Jul; 87(14):8075-84. PubMed ID: 23678186
[TBL] [Abstract][Full Text] [Related]
115. Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB.
Calder VL; Bondeson J; Brennan FM; Foxwell BM; Feldmann M
Scand J Immunol; 2003 Mar; 57(3):261-70. PubMed ID: 12641655
[TBL] [Abstract][Full Text] [Related]
116. An engineered novel lentivector specifically transducing dendritic cells and eliciting robust HBV-specific CTL response by upregulating autophagy in T cells.
Ma S; Chen X; Tan Q; Li D; Dai S; Wu S; Yu Y; Zang G; Tang Z
Cell Cycle; 2018; 17(10):1220-1234. PubMed ID: 30019620
[TBL] [Abstract][Full Text] [Related]
117. Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8
Takahama S; Yoshio S; Masuta Y; Murakami H; Sakamori R; Kaneko S; Honda T; Murakawa M; Sugiyama M; Kurosaki M; Asahina Y; Takehara T; Appay V; Kanto T; Yamamoto T
Front Immunol; 2023; 14():1257113. PubMed ID: 37920475
[TBL] [Abstract][Full Text] [Related]
118. Natural Killer Cells Induce CD8
Liu S; Xu C; Yang F; Zong L; Qin Y; Gao Y; Su Q; Li T; Li Y; Xu Y; Zheng M
Front Immunol; 2022; 13():884290. PubMed ID: 35874664
[TBL] [Abstract][Full Text] [Related]
119. A mutant HBs antigen (HBsAg)183-191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients.
Liu HG; Fan ZP; Chen WW; Yang HY; Liu QF; Zhang H; Tien P; Wang FS
Clin Exp Immunol; 2008 Mar; 151(3):441-7. PubMed ID: 18234055
[TBL] [Abstract][Full Text] [Related]
120. A systematic comparison reveals dynamic differences in early adaptive immune responses of acute-resolving versus chronic HBV replication.
Wang Q; Liu Y; Luo J; Yang S; Wang L; Lu Y; Feng X; Yang X; Sutter K; Dittmer U; Lu M; Zheng X; Yang D; Liu J
J Med Virol; 2023 Mar; 95(3):e28670. PubMed ID: 36916726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
